DelRicht Research Partners with Dr. Sean Kerby of Gulfport Memorial Hospital

GULFPORT, MS –

Expanding Access to Advanced Treatments in Gulfport

Dr. Sean Kerby of Gulfport Memorial Hospital has partnered with DelRicht Research to bring advanced medical treatments to patients in Gulfport, Mississippi. This partnership aims to provide patients with access to cutting-edge treatments while also advancing medical research.

Gulfport Memorial Hospital is a leading medical center in Mississippi that provides a wide range of healthcare services to patients. Dr. Sean Kerby, Chief Medical Officer at Gulfport Memorial, expressed his enthusiasm for the partnership, saying, “We are excited to work with DelRicht Research to bring innovative medical treatments to our patients. This partnership has the potential to make a significant difference in the health of the community.”

“We are excited to work with DelRicht Research to bring innovative medical treatments to our patients. This partnership has the potential to make a significant difference in the health of the community.”

— Dr. Sean Kerby, Principal Investigator at DelRicht Research

DelRicht Research is a clinical research organization that conducts clinical trials for new medical treatments. The organization has a strong track record of conducting successful clinical trials across the country. Tyler Hastings, Managing Partner at DelRicht Research, expressed his excitement about the partnership, stating, “We are honored to work with Gulfport Memorial to advance medical research and provide cutting-edge treatments to patients in Gulfport. We believe that this partnership will make a significant impact on the community.”

“We are honored to work with Gulfport Memorial to advance medical research and provide cutting-edge treatments to patients in Gulfport. We believe that this partnership will make a significant impact on the community.”

— Tyler Hastings, Managing Partner at DelRicht Research

Early Trial Successes in Alzheimer’s and Diabetes

The partnership between Gulfport Memorial and DelRicht Research has already led to several successful clinical trials. One such trial focused on a new treatment for Alzheimer’s disease, which is a significant issue for many patients in the community. The trial showed promising results, with patients experiencing an improvement in cognitive function.

Another clinical trial conducted by the partnership focused on new treatments for diabetes, which also showed promising results. Patients with type 2 diabetes reported improved blood sugar control and a reduction in the need for insulin. These successful clinical trials are just the beginning of what the partnership between Gulfport Memorial and DelRicht Research can achieve for patients in Gulfport.

Meaningful Impact on Patient Care and Research

The impact of the clinical trials conducted by the partnership is significant. In 2021, Gulfport Memorial conducted 16 clinical trials, with 245 participants enrolled in those trials. These trials covered a wide range of medical conditions, including cancer, Alzheimer’s disease, diabetes, and hypertension. The success of these trials has contributed to the advancement of medical research and provided patients with access to innovative treatments.

The partnership between Gulfport Memorial and DelRicht Research has also contributed to the economic growth of Gulfport. According to a report by the Clinical Research Department at Gulfport Memorial, the hospital generated over $1.5 million in revenue from clinical trials in 2021. Additionally, the clinical trials conducted by the partnership have created new jobs in Gulfport, including research nurses and coordinators.

Looking Ahead: Advancing Research Through Continued Collaboration

Overall, the partnership between Gulfport Memorial and DelRicht Research is a significant step forward in providing advanced medical treatments to patients in Gulfport. Dr. Kerby and Tyler Hastings are both committed to continuing their partnership and expanding the range of clinical trials available to patients in the community. As Dr. Kerby notes, “We are dedicated to providing the best healthcare services to our patients, and this partnership allows us to provide cutting-edge care to our community.”

The success of the clinical trials conducted by the partnership highlights the importance of clinical research for patients and the community at large. By participating in clinical trials, patients have the opportunity to access innovative treatments that may not yet be available on the market. This can be particularly beneficial for patients with chronic or life-threatening conditions who have exhausted traditional treatment options.

In conclusion, the partnership between Gulfport Memorial and DelRicht Research is a significant development in advancing medical treatments for patients in Gulfport, Mississippi. The partnership has already conducted successful clinical trials for Alzheimer’s disease and diabetes, among other conditions. The success of these trials has contributed to the advancement of medical research and provided patients with access to innovative treatments. The partnership is expected to lead to further clinical trials that can improve patient outcomes and expand understanding of various medical conditions.